erythromycin has been researched along with betamethasone in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (14.29) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Theunissen, I; van Lierde, M | 1 |
| Bowyer, A; McColl, I | 1 |
| Doria, V; Ghidini, A; Kirn, V; Korker, V | 1 |
| Gurbuz, A; Kabaca, C; Karateke, A | 1 |
| Cholongitas, E; Ioannidou, D; Kokolakis, GP; Krüger-Krasagakis, S | 1 |
1 trial(s) available for erythromycin and betamethasone
| Article | Year |
|---|---|
Erythromycin treatment in idiopathic preterm labor.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Betamethasone; Double-Blind Method; Drug Therapy, Combination; Erythromycin; Female; Humans; Infant Mortality; Infant, Newborn; Obstetric Labor, Premature; Pregnancy; Prospective Studies; Ritodrine; Tocolysis; Tocolytic Agents; Treatment Outcome | 2004 |
13 other study(ies) available for erythromycin and betamethasone
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Preterm premature rupture of the membranes: neonatal outcome in 215 cases of an active conservative management.
Topics: Ampicillin; Betamethasone; Erythromycin; Female; Fetal Membranes, Premature Rupture; Humans; Pregnancy; Pregnancy Outcome; Ritodrine | 1989 |
The role of erythrasma in pruritus ani.
Topics: Adult; Betamethasone; Erythromycin; Humans; Male; Middle Aged; Nocardia Infections; Pruritus Ani | 1966 |
Successful outcome after antibiotic treatment of postamniocentesis membrane rupture and chorioamnionitis in multiple pregnancy.
Topics: Adult; Amniocentesis; Ampicillin; Anti-Inflammatory Agents; Betamethasone; Chorioamnionitis; Clindamycin; Drug Administration Schedule; Drug Therapy, Combination; Erythromycin; Female; Fetal Death; Fetal Membranes, Premature Rupture; Gentamicins; Humans; Infant, Newborn; Injections, Intravenous; Male; Oligohydramnios; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, Second; Triplets | 1999 |
Guttate psoriasis occurring on varicella lesions.
Topics: Betamethasone; Chickenpox; Child, Preschool; Erythromycin; Humans; Male; Psoriasis; Tacrolimus; Treatment Outcome | 2010 |